CD38 and neoplasm: As alternative approaches, using the all-trans retinoic acid or the histone deacetylase inhibitor panobinostat could selectively upregulate the expression of CD38 on MM tumor cells that might augment CAR-T cell cytotoxicity, and diminish the toxicity on healthy cells [90, 91].